BIOGROUP Sustainability Profile
BIOGROUP, a leading player in the French biotechnology sector, is headquartered in France and operates extensively across Europe. Founded in 2003, the company has established itself as a pioneer in the field of medical diagnostics and laboratory services, focusing on innovative solutions that enhance patient care. With a diverse portfolio that includes clinical biology, genetic testing, and specialised laboratory services, BIOGROUP stands out for its commitment to quality and precision. The company has achieved significant milestones, including the expansion of its laboratory network and the introduction of cutting-edge diagnostic technologies. Recognised for its excellence in the industry, BIOGROUP continues to strengthen its market position through strategic partnerships and a dedication to research and development, ensuring it remains at the forefront of the biotechnology landscape.
DitchCarbon Score
How does BIOGROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOGROUP's score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOGROUP's reported carbon emissions
In 2022, BIOGROUP reported total carbon emissions of approximately 554,774,000 kg CO2e, comprising 5,001,000 kg CO2e from Scope 1, 887,000 kg CO2e from Scope 2, and a significant 548,886,000 kg CO2e from Scope 3 emissions. This represents a decrease from 2021, where total emissions were about 616,691,000 kg CO2e, with Scope 1 emissions at 5,557,000 kg CO2e, Scope 2 at 986,000 kg CO2e, and Scope 3 at 610,148,000 kg CO2e. BIOGROUP is committed to reducing its carbon footprint, with specific near-term targets set for Scope 1 and Scope 2 emissions. The company aims to achieve these reductions between 2023 and 2025, although specific percentage targets have not been disclosed. This commitment reflects BIOGROUP's dedication to actively combat climate change and preserve the environment. The emissions data is cascaded from its parent company, SCM BIOGROUP, indicating a corporate family relationship that influences its sustainability reporting and targets. For further details on their climate initiatives, refer to their 2023 RSE report.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 5,557,000 | 0,000,000 |
| Scope 2 | 986,000 | 000,000 |
| Scope 3 | 610,148,000 | 000,000,000 |
How Carbon Intensive is BIOGROUP's Industry?
How Carbon Intensive is BIOGROUP's Location?
BIOGROUP's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BIOGROUP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
